Legal & General Group
EVMN icon

Legal & General Group’s Evommune Inc EVMN Stock Holding History

Legal & General Group’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
8,521
+7,602
+827% +$177K ﹤0.01% 2628
2026
Q1 		$21.1K Buy
919
+519
+130% +$11.7K ﹤0.01% 2946
2025
Q4 		$6.85K Buy
+400
New +$7.51K ﹤0.01% 3314

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Legal & General Group's EVMN Position: Q2 2026 in Review

Legal & General Group increased its Evommune Inc (EVMN) stake by 827% in Q2 2026, buying an estimated $177K and bringing the position to 8,521 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #2628.

Legal & General Group first reported a position in EVMN in Q4 2025 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Legal & General Group held 8,521 shares of Evommune Inc worth $113K as of Q2 2026.
  • Legal & General Group bought 7,602 Evommune Inc shares in Q2 2026, an estimated $177K.
  • Evommune Inc made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2628 holding.
  • Legal & General Group first reported a position in Evommune Inc in Q4 2025 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.